Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clearant Inc.

Latest From Clearant Inc.

Sports Medicine: Game-Changing Technologies

Sports medicine is the fastest growing specialty in orthopedics, attracting more than 25% of orthopedic residents seeking fellowships for the 2010 training year. Since many sports injuries occur in the young athlete, the way an injury is treated early on may be the determining factor in preventing progressive joint changes and the early onset of degenerative diseases such as osteoarthritis. The promise of new biomaterials and biologics for repairing or replacing supporting soft tissue structures will have a big impact on the orthopedics market for some time to come.

Medical Device

NovaSterilis Inc.

When thwarted by the lack of a suitable method to sterilize biomaterials for use in humans, Robert Langer's lab at the Massachusetts Institute of Technology simply invented supercritical carbon dioxide sterilization technology to solve the problem, forming start-up NovaSterilis.

Medical Device

Start-Up Previews (11/03)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, The New Movement in Spine, features profiles of Archus Orthopedics Inc., AxioMed Spine Corp., Gelifex Inc. and Replication Medical Inc. Plus these Start-Ups Across Health Care: Advanced Circulatory Systems Inc., Ambrx Inc., Clearant Inc., Compound Therapeutics Inc., Hydra Biosciences Inc., NanoBio Corp., Phenomix Corp. and VisEn Medical Inc.

Clearant Inc.

Clearant Inc. eventually aims to apply its gamma pathogen inactivation technology to the blood transfusion market, but it is starting with sterilization of tissue implants and other biological products where the regulatory hurdles are lower and the timeline to commercialization is shorter.

See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Infection Control-Sterilization